XML 90 R48.htm IDEA: XBRL DOCUMENT v3.19.3
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Goodwill [Line Items]          
Goodwill, impairment $ 0        
Intangible assets, indefinite life, discount rate percentage 12.50%     12.50%  
Intangible asset amortization       $ 5,764,000 $ 4,941,000
Expected annual amortization expense, remainder of 2019 $ 16,600,000     16,600,000  
Expected annual amortization expense, in 2020 66,600,000     66,600,000  
Expected annual amortization expense, in 2021 65,500,000     65,500,000  
Expected annual amortization expense, in 2022 62,000,000.0     62,000,000.0  
Expected annual amortization expense, in 2023 61,100,000     61,100,000  
Expected annual amortization expense, in 2024 60,300,000     60,300,000  
Expected annual amortization expense, thereafter $ 549,000,000.0     $ 549,000,000.0  
Contract Manufacturing Customer, Notified By FDA To Remove Product From Market | Private Label | Customer Relationships          
Goodwill [Line Items]          
Intangible asset amortization   $ 5,800,000      
Metasurg | Orthopedics and Tissue Technologies          
Goodwill [Line Items]          
Intangible asset amortization     $ 4,900,000    
Impairment charge, out of period adjustment included in original impairment     2,500,000   2,500,000
Metasurg | Orthopedics and Tissue Technologies | Completed Technology          
Goodwill [Line Items]          
Remaining net book value     $ 2,300,000   $ 2,300,000